JP2024508088A - 全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス - Google Patents
全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス Download PDFInfo
- Publication number
- JP2024508088A JP2024508088A JP2023541092A JP2023541092A JP2024508088A JP 2024508088 A JP2024508088 A JP 2024508088A JP 2023541092 A JP2023541092 A JP 2023541092A JP 2023541092 A JP2023541092 A JP 2023541092A JP 2024508088 A JP2024508088 A JP 2024508088A
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- oncolytic
- glycoprotein
- fuson
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163200011P | 2021-02-09 | 2021-02-09 | |
| US63/200,011 | 2021-02-09 | ||
| US202163263528P | 2021-11-04 | 2021-11-04 | |
| US63/263,528 | 2021-11-04 | ||
| PCT/US2022/015703 WO2022173767A1 (en) | 2021-02-09 | 2022-02-08 | Oncolytic virus for systemic delivery and enhanced anti-tumor activities |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508088A true JP2024508088A (ja) | 2024-02-22 |
| JP2024508088A5 JP2024508088A5 (cg-RX-API-DMAC7.html) | 2025-02-18 |
Family
ID=80623426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541092A Pending JP2024508088A (ja) | 2021-02-09 | 2022-02-08 | 全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240123004A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4291216A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508088A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022219921A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3202849A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022173767A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230295661A1 (en) * | 2022-03-16 | 2023-09-21 | University Of Houston System | Persistent hsv gene delivery system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008546801A (ja) * | 2005-06-23 | 2008-12-25 | ベイラー カレッジ オブ メディスン | 癌の治療のための単純ヘルペスウイルス2型変異体の使用 |
| JP2019500909A (ja) * | 2016-01-08 | 2019-01-17 | レプリミュン リミテッド | 腫瘍溶解性ウイルス株 |
| WO2019232379A1 (en) * | 2018-05-31 | 2019-12-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Antigenically stealthed oncolytic viruses |
| JP2020525435A (ja) * | 2017-06-21 | 2020-08-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 血液悪性腫瘍に対するcd47標的化治療のための投与パラメータ |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8200523A (nl) | 1982-02-11 | 1983-09-01 | Univ Leiden | Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna. |
| US4879236A (en) | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| EP0273085A1 (en) | 1986-12-29 | 1988-07-06 | IntraCel Corporation | A method for internalizing nucleic acids into eukaryotic cells |
| US4952500A (en) | 1988-02-01 | 1990-08-28 | University Of Georgia Research Foundation, Inc. | Cloning systems for Rhodococcus and related bacteria |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
| US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5322783A (en) | 1989-10-17 | 1994-06-21 | Pioneer Hi-Bred International, Inc. | Soybean transformation by microparticle bombardment |
| US5484956A (en) | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
| US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US5610042A (en) | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
| DK0604662T3 (da) | 1992-07-07 | 2008-10-20 | Japan Tobacco Inc | Fremgangsmåde til transformering af monocotyledon |
| US5702932A (en) | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
| AU670316B2 (en) | 1992-07-27 | 1996-07-11 | Pioneer Hi-Bred International, Inc. | An improved method of (agrobacterium)-mediated transformation of cultured soybean cells |
| DE4228457A1 (de) | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
| GB9222888D0 (en) | 1992-10-30 | 1992-12-16 | British Tech Group | Tomography |
| US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
| FR2722208B1 (fr) | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
| US5871986A (en) | 1994-09-23 | 1999-02-16 | The General Hospital Corporation | Use of a baculovirus to express and exogenous gene in a mammalian cell |
| US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
| US5981274A (en) | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
| US6013265A (en) | 1996-10-22 | 2000-01-11 | University Of Maryland, Baltimore | Vaccine composition for herpes simplex virus and methods of using |
| US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
| US20150246086A1 (en) | 2005-06-23 | 2015-09-03 | The University Of Houston System | Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy |
| WO2012071276A1 (en) | 2010-11-23 | 2012-05-31 | Xiaoliu Zhang | Oncolytic virus as an inducer for innate antitumor immunity |
-
2022
- 2022-02-08 WO PCT/US2022/015703 patent/WO2022173767A1/en not_active Ceased
- 2022-02-08 JP JP2023541092A patent/JP2024508088A/ja active Pending
- 2022-02-08 EP EP22707286.5A patent/EP4291216A1/en active Pending
- 2022-02-08 CA CA3202849A patent/CA3202849A1/en active Pending
- 2022-02-08 US US18/264,737 patent/US20240123004A1/en active Pending
- 2022-02-08 AU AU2022219921A patent/AU2022219921A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008546801A (ja) * | 2005-06-23 | 2008-12-25 | ベイラー カレッジ オブ メディスン | 癌の治療のための単純ヘルペスウイルス2型変異体の使用 |
| JP2019500909A (ja) * | 2016-01-08 | 2019-01-17 | レプリミュン リミテッド | 腫瘍溶解性ウイルス株 |
| JP2020525435A (ja) * | 2017-06-21 | 2020-08-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 血液悪性腫瘍に対するcd47標的化治療のための投与パラメータ |
| WO2019232379A1 (en) * | 2018-05-31 | 2019-12-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Antigenically stealthed oncolytic viruses |
Non-Patent Citations (6)
| Title |
|---|
| FAN Q. ET AL.: "Natural selection of glycoprotein B mutations that rescue the small-plaque phenotype of fusion-impai", MBIO, vol. 9, 5, JPN7026000341, 16 October 2018 (2018-10-16), pages 01948 - 18, ISSN: 0005787699 * |
| FU X. ET AL.: "Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and", ONCOTARGET, vol. 9, 77, JPN7026000338, 2 October 2018 (2018-10-02), pages 34543 - 34553, ISSN: 0005787696 * |
| HUA L. ET AL.: "Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinic", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 19, 8, JPN7026000339, 13 May 2019 (2019-05-13), pages 845 - 854, ISSN: 0005787697 * |
| LIU XQ. ET AL.: "Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envero", DRUG DELIVERY, vol. 25, 1, JPN7026000337, 4 December 2018 (2018-12-04), pages 1950 - 1962, ISSN: 0005787695 * |
| PASSARO C. ET AL.: "Arming an oncolytic herpes simplex virus type 1 with a single-chain fragment variable antibody again", CLINICAL CANCER RESEARCH, vol. 25, 1, JPN7026000340, 2 October 2018 (2018-10-02), pages 290 - 299, ISSN: 0005787698 * |
| RAUCH DA. ET AL.: "Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spre", JOURNAL OF VIROLOGY, vol. 74, 24, JPN7026000342, December 2000 (2000-12-01), pages 11437 - 11446, ISSN: 0005787700 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3202849A1 (en) | 2022-08-18 |
| EP4291216A1 (en) | 2023-12-20 |
| AU2022219921A1 (en) | 2023-06-29 |
| US20240123004A1 (en) | 2024-04-18 |
| WO2022173767A1 (en) | 2022-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5284780B2 (ja) | 癌の治療のための単純ヘルペスウイルス2型変異体の使用 | |
| AU2003258060B2 (en) | Potent oncolytic herpes simplex virus for cancer therapy | |
| US12414973B2 (en) | Antigenically stealthed oncolytic viruses | |
| KR20230117107A (ko) | 단백질 페이로드 방출 | |
| MXPA02002142A (es) | Promotor especifico de la celula y/o especifico del tumor, que re-selecciona como objetivo la expresion del gen gamma 35.5 de herpes. | |
| US20240123004A1 (en) | Oncolytic virus for systemic delivery and enhanced anti-tumor activities | |
| JP7460850B2 (ja) | 多重標的化組換えヘルペスシンプルレックスウイルス及びその用途 | |
| US20150246086A1 (en) | Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy | |
| CN116782917A (zh) | 用于全身递送的溶瘤病毒及增强的抗肿瘤活性 | |
| US20230295661A1 (en) | Persistent hsv gene delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250207 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250207 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260123 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260203 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260803 |